ATP Synthesis-IN-3
Product Specifications
CAS Number
3032416-36-4
Target
ATPase, PKA
Related Pathways
Membrane transporter/Ion channel, Tyrosine Kinase/Adaptors
Bioactivity
ATP Synthesis-IN-3 (compound 31) is an inhibitor of ATP hydrolysis that provides a protective effect during myocardial ischemia. It increases ATP levels in ischemic myocardial cells, enhances the phosphorylation of PKA and substrate proteins, and inhibits ischemia-induced apoptosis (cell apoptosis) .
Smiles
N=1C(=CC=2C(=NN(C2C1N3CCOCC3)CC4=CC=C(OC)C=C4)C=5C=CC=CC5)NC6=CC=C(C=C6)N7CCN(C)CC7
Molecular Formula
C35H39N7O2
Molecular Weight
589.73
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PX-TA1319-01 50 µg
Setoxaximab Biosimilar - Anti-Stx2, SLT-II mAb - Research Grade
Sign In for Pricing
View Details PX-TA1319-02 100 µg
Setoxaximab Biosimilar - Anti-Stx2, SLT-II mAb - Research Grade
Sign In for Pricing
View Details